Dr. Dipanjana Datta, with 16 years of experience, is a leading geneticist at Manipal Hospital, Mukundapur. Trained in India and the USA, she is a certified genetic counsellor and a pioneer in biomarker discovery. She also serves as West Bengal Coordinator for the Organisation of Rare Diseases and holds a patent in head and neck cancer biomarkers. Fluent in English, Hindi, and Bengali, she combines expertise with compassionate, patient-centric care.

Educational Qualifications:

• M.Sc. – Biochemistry & Molecular Biology, University of Calcutta
• PhD – Genetics & Molecular Biology, IICB, Kolkata
• Postdoctoral Fellowship – Virginia Commonwealth University (VCU), USA
• BGCI Level II Certification – Genetic Counselling

Professional Experiences:

• Consultant – Medical Genetics, Manipal Hospitals Mukundapur
• West Bengal Coordinator – Organisation of Rare Diseases
• Executive Member – West Bengal Chapter of Foetal Medicine
• Principal – Diploma Course in Early Intervention in Neurodevelopmental Disorders

Professional Memberships:

• American Society for Human Genetics (ASHG)
• Indian Society for Human Genetics (ISHG)
• Calcutta Consortium of Human Genetics (CCHuGe)
• Society for Biological Chemists (SBC)
• Indian Immunological Society (IIS)
• Indian Genome Variation Consortium

Awards and Achievements:

• Patent for biomarker discovery in metastasis (head & neck cancer)
• Widely recognised speaker and researcher in genetics and rare diseases
• Key leadership role in rare disease and foetal medicine organisations

Publications:

• Association of IL1B with Helicobacter Pylori-induced Duodenal Ulcer in the Eastern Indian population and Elucidation of the Signalling Pathways of IL1B that Regulate Gastric Acid Secretion.
• Identification and Elucidation of mu-opioid Receptors that Respond to Morphine in the Gut; their Splicing Isoforms and the Role of these Splice Variants in Developing Morphine Tolerance in the Gut.
• The effect of HIV on Myenteric Neurones.
• Biomarker Discovery for Predicting Metastasis in Oral Cancer in the Indian Population.
• Indian Genome Variation Database.
• Idiopathic Spontaneous Abortions.
• Y Chromosome Microdeletions in the Indian Population.
• Cystic Fibrosis, Prenatal Genetics, Risk Prediction, etc.
• Published paper titled ‘Hypercalcemia in an Infant with Primary Hyperoxaluria Type 2: A Novel Association’ in Indian J Nephrology, 2023
• Published paper titled ‘High Incidence of COL4A Genetic Variants Among a Cohort of Children With Steroid-Resistant Nephrotic Syndrome From Eastern India’ in Kidney Int Reports, 2022
• Published paper titled ‘Aromatase deficiency in a tall man: A case report of two novel mutations and review of the literature’ in Bone Rep, 2022
• Published paper titled ‘A Rare Differences of Sex Development: Male Sex Reversal Syndrome (NonSyndromic 46, XX with Negative Sex-Determining Region of the Y Chromosome Gene)’ in J Indian Association Paediatric Surgery, 2023
• Other publications in numerous International Journals, such as the Proceedings of the National Academy of Sciences (PNAS), Journal of Nephrology, Plos One, International Journal of Gastroenterology, etc.